Pharma and Biotech
Directorate Change | 29-Feb-2024 | 18:00 | RNS |
Share Incentive Plan - Director/PDMR Shareholding | 13-Feb-2024 | 16:00 | RNS |
Holding(s) in Company | 02-Feb-2024 | 16:30 | RNS |
Issue of Equity and Total Voting Rights | 01-Feb-2024 | 12:00 | RNS |
Expansion of leadership team | 22-Jan-2024 | 07:00 | RNS |
Share Incentive Plan - Director/PDMR Shareholding | 11-Jan-2024 | 17:30 | RNS |
Employee Stock Purchase Plan - PDMR Notification | 11-Jan-2024 | 17:30 | RNS |
FY23 trading update | 09-Jan-2024 | 07:00 | RNS |
Presentation at 42nd Annual J.P. Morgan Conference | 03-Jan-2024 | 07:00 | RNS |
Appointment of Two Non-Executive Directors | 19-Dec-2023 | 14:00 | RNS |
Share Incentive Plan - Director/PDMR Shareholding | 12-Dec-2023 | 17:00 | RNS |
Nanopore Community Meeting Technology Update | 07-Dec-2023 | 16:30 | RNS |
Issue of Equity and Total Voting Rights | 01-Dec-2023 | 17:00 | RNS |
National Australian rare disease programme | 30-Nov-2023 | 07:00 | RNS |
Share Incentive Plan - Director/PDMR Shareholding | 13-Nov-2023 | 17:00 | RNS |
Currency | UK Pounds |
Share Price | 104.40p |
Change Today | -2.90p |
% Change | -2.70 % |
52 Week High | 275.00 |
52 Week Low | 92.75 |
Volume | 227,478 |
Shares Issued | 862.59m |
Market Cap | £900.54m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
14:55 | 612 @ 104.40p |
14:50 | 431 @ 104.50p |
14:50 | 324 @ 104.50p |
14:50 | 45 @ 104.60p |
14:48 | 48 @ 104.60p |
CEO | Gurdial (Gordon) Sanghera |
CFO | Nick Keher |
You are here: research